CTLA4 and neoplasm: However, some tumor cells may have the ability to express both CTLA-4 and PD-L1 (31, 32); inhibiting the antitumor response, and blocking this expression is the basis for the immunotherapy awarded in 2018 with the Nobel Prize in Physiology or Medicine to James P. Allison and Tasuku Honjo.